Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah McGrath

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
BMC Rheumatology|April 21, 2025
Transitional and CD21<sup>-</sup> PD-1<sup>+</sup> B cells are associated with remission in early rheumatoid arthritisSarah McGrath, Boel Sundbeck, Katrin Thorarinsdottir, et al.
Clinical & Translational Immunology|October 4, 2024
Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cellsKathrin Kläsener, Nadja Herrmann, Liliana Håversen, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
BMC Rheumatology|April 21, 2025
Transitional and CD21<sup>-</sup> PD-1<sup>+</sup> B cells are associated with remission in early rheumatoid arthritisSarah McGrath, Boel Sundbeck, Katrin Thorarinsdottir, et al.
Clinical & Translational Immunology|October 4, 2024
Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cellsKathrin Kläsener, Nadja Herrmann, Liliana Håversen, et al.
Pageof 3